Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arno P.S., and Feiden K.L., 1992, Against the odds: the story of AIDS drug development, politics and profits. New York: HarperCollins.
Attaran A, and Sachs T, 2001, Defining and refining international donor support for combating the AIDS pandemic. Lancet 357: 57–61.
Auvert R., et al., 2005, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2: e298.
Barlett J.G., 2002, The Johns Hopkins Hospital 2002 Guide to medical care of patients with HIV infection. 10th edn., Baltimore: Lippincot Williams & Wilkins. Cited in Palmer, 2003.
Boston.com, 2006, CDC's revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. September 22. www.boston.com/yourlife/health/
Centers for Disease Control (CDC), 1981a, Pneumocystis pneumonia – Los Angeles. Morb Mort Wkly Rep 30: 250–252.
Centers for Disease Control (CDC), 1981b, Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. Morb Mort Wkly Rep 30: 305–308.
Centers for Disease Control (CDC), 1982a, Pneumocystis carinii pneumonia among persons with haemophilia. Morb Mort Wkly Rep 31: 353–354, 360–361.
Centers for Disease Control (CDC), 1982b, Acquired Immune Deficiency Syndrome (AIDS): precautions for clinical and laboratory staffs. Morb Mort Wkly Rep 31: 377–380.
Centers for Disease Control (CDC), 1984, Summary – cases specified notifiable diseases, United States. Morb Mort Wkly Rep 33: 4–5.
Connor E.M., et al., 1994, Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331: 1173–1180.
Duesberg P., and Rasnick D., 1998, The AIDS dilemma: drug diseases blamed on a passenger virus. Genetica 104: 85–132.
Food and Drug Administration, 2006, FDA News. Washington DC: US Department of Health and Human Services. www.fda.gov. 12 July.
Glynn M., and Rhodes P., 2005, Estimated HIV prevalence in the United States at the end of 2003. Presented at the National HIV Prevention Conference, Atlanta, 12–15 June. www.aegis.com/conferences/nhivpc/2005/T1–B1101.
Gottlieb M.S., 2001, AIDS – Past and future. N Engl J Med 344: 1788–1790.
Gottlieb M.S., et al., 1981, Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305: 1425–1431.
Kaiser Network, 2006, Global HIV/AIDS Timeline. www.kff.org/hivaids/timeline
Leonidas J.R., and Hyppolite N., 1983, Haiti and the acquired immunodeficiency syndrome. Ann Int Med 98: 1020–1021.
Masquelier B., et al., 2005, Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms data from seroconverters in the CASCADE collaboration from 1987 to 2003. J AIDS 40: 505–511.
Masur H., et al., 1981, An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305: 1431–1438.
Merson M.H., 2006, The HIV-AIDS pandemic at 25–The global response. N Engl J Med 354: 2421–2417.
New Mexico AIDS Education and Training Center, 2006, Fact Sheet 158. AIDS myths and misunderstandings. University of New Mexico Health Sciences Center. www.aidsinfonet.org Revised 18 April 2006.
New Mexico AIDS Education and Training Center, 2006, Fact Sheet 206. How to spot HIV/AIDS fraud. University of New Mexico Health Sciences Center. www.aidsinfonet.org Revised 10 August 2006.
Nwokike J.L., 2005, Baseline data and predictors of adherence in patients on anti-retroviral therapy in Maun General Hospital, Botswana. Essential Drugs Monitor 34: 12–13.
Pallela F.J. Jr., et al., 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 238: 853–860.
Palmer C., 2003, HIV treatments and highly active anti-retroviral therapy. Austr Prescr 26 (3): 59–61.
Sepkowitz K.A., 2001, AIDS – The first 20 years. N Engl J Med 344: 1764–1772.
Sepkowitz K.A., 2006, One disease, two epidemics – AIDS at 25. N Engl J Med 354: 2411–2414.
Shafer R.W., et al., 1989, Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim – sulfamethoxazole in AIDS patients with previous allergic reactions. J AIDS 2: 389–393.
Shilts R., 1987, And the band played on – politics, people and the AIDS epidemic. New York: St. Martin's Press.
Siegal F.P., et al., 1981, Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305: 1439–1444.
Steinbrook R., and Drazen J.M., 2001, AIDS – Will the next 20 years be different (Editorial). N Engl J Med 344: 1781–1782.
Stewart G.T., et al., 2000, The Durban Declaration is not accepted by all. Nature 407: 286.
Stover J., et al., 2006, The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science 311: 1474–1476.
Swarns R.L., 2001, Drug makers drop South Africa suit over AIDS medicine. New York Times. April 20: A1. Cited in: Steinbrook & Drazen, 2001.
UNAIDS, 2006, 2006 Report on the global AIDS epidemic. Geneva: UNAIDS. www.unaids.org
UNAIDS/WHO, 2005, AIDS epidemic update. Geneva: UNAIDS-WHO, p 5.
Website: www.hiv.bg/redribbon.history.english.htm. Accessed on 20 September 2006.
Website: www.lifepositive.com/aids.html. Accessed on 20 September 2006.
Whyte S.R., et al., 2005, Accessing retroviral drugs: dilemmas for families and health workers. Essent Drugs Monit 34: 14–15.
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
(2007). Epilogue. In: HIV and AIDS: Basic Elements and Priorities. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5789-2_29
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5789-2_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5788-5
Online ISBN: 978-1-4020-5789-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)